← Leaderboards
Mariano Sebastian Viapiano
Ohio State University
$3,465,050
Attributed
$3,465,050
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $486K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,465,050 · 5
By mechanism
R21$2,190,863 · 4
R01$1,274,187 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Balveen Kaur$17,543,202
- Haitao Wen$7,990,382
- Ana Clara Pereira Azevedo-Pouly$139,125
- Kalpana Ghoshal$5,864,666
- Ly James Lee$3,875,706
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellMalignant Neoplasm Of BrainMolecularTumorCellsGliomaBrainSignal TransductionProteinsTumor GrowthTumor Cell InvasionRecurrenceBrain NeoplasmsResponseIn VitroIn VivoEnvironmentMalignant GliomaPathway InteractionsFibulinS1-5 ProteinExtracellular MatrixBrain TissueExtracellular Matrix Proteins
Grant awards (13)
Targeting scaffolding proteins to disrupt radioresistance in glioblastoma$448,250
R21 · FY2024 · NS · contact PI
Targeting the tumor matrix as immune-boosting strategy for malignant gliomas$202,500
R21 · FY2020 · NS · contact PI
Targeting cell polarity to disrupt the interaction of glioblastomas with the neural environment$202,500
R21 · FY2020 · NS · contact PI
Targeting the tumor matrix as immune-boosting strategy for malignant gliomas$243,000
R21 · FY2019 · NS · contact PI
Targeting cell polarity to disrupt the interaction of glioblastomas with the neural environment$243,000
R21 · FY2019 · NS · contact PI
Chimeric anti-fibulin-3 reagents for targeted therapy of glioblastoma$427,760
R21 · FY2016 · NS · contact PI
Chimeric Anti-Fibulin-3 Reagents For Targeted Therapy Of Glioblastoma$423,853
R21 · FY2015 · NS · contact PI
Targeting the Tumor Matrix as Anti-Invasive and Sensitizing Strategy for Glioma$269,487
R01 · FY2014 · CA · contact PI
Targeting the Tumor Matrix as Anti-Invasive and Sensitizing Strategy for Glioma$260,438
R01 · FY2013 · CA · contact PI
Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma$180,499
R01 · FY2012 · CA · contact PI
Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma$65,057
R01 · FY2012 · CA · contact PI
Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma$245,556
R01 · FY2011 · CA · contact PI
Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma$253,150
R01 · FY2010 · CA · contact PI